GSK3beta, indeed, co-localizes with alpha-synuclein in Lewy bodies and its expression is increased in postmortem brain from PD patients (Nagao and Hayashi, 2009) and in experimental models of PD associated with alpha-synuclein accumulation (Golpich et al., 2015). Here, GSK3B is linked to Parkinson disease.